Literature DB >> 22991331

Increased sphingoid base-1-phosphates and failure of neural tube closure after exposure to fumonisin or FTY720.

Janee Gelineau-van Waes1, Mark A Rainey, Joyce R Maddox, Kenneth A Voss, Andrew J Sachs, Nicole M Gardner, Justin D Wilberding, Ronald T Riley.   

Abstract

BACKGROUND: Fumonisin B(1) (FB(1)) is a mycotoxin produced by a common fungal contaminant of corn. Ingestion of FB(1)-contaminated food is associated with increased risk for neural tube defects (NTDs). FB(1) induces NTDs in inbred LM/Bc mice. FB(1) inhibits ceramide synthase in de novo sphingolipid biosynthesis, resulting in accumulation of sphinganine and sphinganine-1-phosphate (Sa1P). Sa1P functions as a ligand for a family of G protein-coupled S1P receptors.
METHODS: Pregnant SWV and LM/Bc mice were treated with FB(1) (20 mg/kg/day intraperitoneally on embryonic day (ED) 7.5-8.5) or the known S1P receptor agonist FTY720 (10 mg/kg/day oral gavage on ED 6.5-8.5). LC/MS was used to detect sphingoid base-1-phosphates in maternal blood spots, plasma, and embryonic tissue. Strain-specific SWV and LM/Bc mouse embryonic fibroblasts (MEFs) and serum free mouse embryo (SFME) neural progenitor cells were treated with FB(1) (40 μM for 24 hr) and LC/MS was used to detect sphingoid base-1-phosphates.
RESULTS: FTY720 induced NTDs in both the SWV and the LM/Bc strains of mice. Sphinganine-1-P (Sa1P) and FTY720-P were elevated in the blood spots and plasma of mice treated with FB(1) or FTY720, respectively. FTY720-P was elevated in ED 9.5 exencephalic embryos. Sa1P was elevated in SFME and MEF cells treated with FB(1), and Sa1P was higher in MEFs generated from the FB(1)-NTD-susceptible LM/Bc strain.
CONCLUSIONS: Elevated sphingoid base-1-P after FB(1) or FTY720 suggest a potential role for these bioactive lipid ligands and activation of S1P receptor signaling pathways in the failure of neural tube closure after FB(1) or FTY720. Sa1P may represent a biomarker for FB(1)-NTD risk assessment.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22991331     DOI: 10.1002/bdra.23074

Source DB:  PubMed          Journal:  Birth Defects Res A Clin Mol Teratol        ISSN: 1542-0752


  12 in total

1.  Ceramide synthase inhibition by fumonisins: a perfect storm of perturbed sphingolipid metabolism, signaling, and disease.

Authors:  Ronald T Riley; Alfred H Merrill
Journal:  J Lipid Res       Date:  2019-05-02       Impact factor: 5.922

2.  Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.

Authors:  Nicole M Gardner; Ronald T Riley; Jency L Showker; Kenneth A Voss; Andrew J Sachs; Joyce R Maddox; Janee B Gelineau-van Waes
Journal:  Toxicol Sci       Date:  2015-12-29       Impact factor: 4.849

Review 3.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

Review 4.  A review of safety-related pregnancy data surrounding the oral disease-modifying drugs for multiple sclerosis.

Authors:  Ellen Lu; Bing Wei Wang; Sura Alwan; Anne Synnes; Leanne Dahlgren; A Dessa Sadovnick; Helen Tremlett
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

5.  Evidence for fumonisin inhibition of ceramide synthase in humans consuming maize-based foods and living in high exposure communities in Guatemala.

Authors:  Ronald T Riley; Olga Torres; Jorge Matute; Simon G Gregory; Allison E Ashley-Koch; Jency L Showker; Trevor Mitchell; Kenneth A Voss; Joyce R Maddox; Janee B Gelineau-van Waes
Journal:  Mol Nutr Food Res       Date:  2015-09-03       Impact factor: 5.914

Review 6.  Neural tube defects: recent advances, unsolved questions, and controversies.

Authors:  Andrew J Copp; Philip Stanier; Nicholas D E Greene
Journal:  Lancet Neurol       Date:  2013-06-19       Impact factor: 44.182

7.  In vivo formation of N-acyl-fumonisin B1.

Authors:  Henning Harrer; Hans Ulrich Humpf; Kenneth A Voss
Journal:  Mycotoxin Res       Date:  2014-10-19       Impact factor: 3.833

8.  Maternal mycotoxin exposure and adverse pregnancy outcomes: a systematic review.

Authors:  Nicholas N A Kyei; Daniel Boakye; Sabine Gabrysch
Journal:  Mycotoxin Res       Date:  2020-01-27       Impact factor: 3.833

9.  Phytic acid decreases deoxynivalenol and fumonisin B1-induced changes on swine jejunal explants.

Authors:  Elisângela Olegário da Silva; Juliana Rubira Gerez; Thalisie do Carmo Drape; Ana Paula F R L Bracarense
Journal:  Toxicol Rep       Date:  2014-05-29

Review 10.  Safety of folic acid.

Authors:  Martha S Field; Patrick J Stover
Journal:  Ann N Y Acad Sci       Date:  2017-11-20       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.